Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 616-995-5 | CAS number: 8018-01-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.474 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 12.5
- Dose descriptor starting point:
- NOAEL
- Value:
- 4.8 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 5.92 mg/m³
- Explanation for the modification of the dose descriptor starting point:
There are no relevant experimental data on repeated exposure by inhalation. A conservative approach is used assuming a two times higher absorption via the inhalation route (end route) as compared to the oral route (starting route).
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable.
- AF for differences in duration of exposure:
- 1
- Justification:
- No further extrapolation factor is needed since a chronic study is already used as starting point.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No allometric scalling is applied for inhalation as the inhalative data is standardized with reference to the respiratory rates. Respiratory rates depend directly on caloric demand, therefore inhalative study results are already extrapolated to humans on the basis of metabolic rate scaling (=allometric scaling).
- AF for other interspecies differences:
- 2.5
- Justification:
- The recommended AF for interspecies differences is used.
- AF for intraspecies differences:
- 5
- Justification:
- The default value for the relatively homogenous group "worker" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- DNEL Derivation is considered conservative, reflecting reasonable worst case assumptions. Therefore, no further AF for remaining uncertainties is applied.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 9.6 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 50
- Dose descriptor starting point:
- NOAEL
- Value:
- 4.8 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 480 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
No repeated dose dermal toxicity study with the test item is available. Therefore, long-term dermal DNEL was derived by route-to-route extrapolation.
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable.
- AF for differences in duration of exposure:
- 1
- Justification:
- No further extrapolation factor is needed since a chronic study was already used as starting point.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- The default allometric scaling factor for the differences between rats and humans is applied.
- AF for other interspecies differences:
- 2.5
- Justification:
- The recommended AF for interspecies differences is used.
- AF for intraspecies differences:
- 5
- Justification:
- The default value for the relatively homogenous group "worker" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- DNEL Derivation is considered conservative, reflecting reasonable worst case assumptions. Therefore, no further AF for remaining uncertainties is applied.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Acute/short term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
General
DNEL derivation for the test item is performed under consideration of the recommendations of ECHA, Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose-response for human health (Version: 2.1, November 2012).
Inhalation
Long term, systemic DNEL – exposure via inhalation (workers)
Using a conservative approach, a worker DNEL (long-term inhalation exposure) is calculated. No repeated dose inhalation toxicity study with the test item is available. Therefore, the long-term inhalation DNEL was derived by route-to-route extrapolation from an oral repeated dose toxicity study:
Based on an OECD TG 453 study with daily dietary administration of the test item at concentration levels of 0, 20, 60, 125 or 750 ppm to Crl: CD BR rats for a period of 52 weeks, a NOAEL for systemic toxicity and carcinogenicity of 125 ppm (4.8 mg/kg bw/d in males and 6.7 mg/kg bw/d in females) was determined. Therefore, the NOAEL of 4.8 mg/kg bw/d is applied as Point of Departure for DNEL derivation.
Step 1: Point of Departure (PoD): NOAEL = 4.8 mg/kg bw/day
Step 2: Modification of PoD:
Standard respiratory volume, human (sRVhuman) for 8 h per person (70 kg): 6.7 m3
Standard respiratory volume of the rat (sRVrat) for 8 hours: 0.38 m3/kg bw
Worker respiratory volume (wRV) for 8 hours with light physical activity per person: 10 m3
Oral absorption of the rat/ inhalation absorption of humans (ABS oral-rat / ABS inh-human): 1/2 (default)
Correction for difference between human and experimental exposure conditions: 7 d rat/5 d worker
Corrected NOAEC (inhalation) for workers:
= 4.8 mg/kg bw/day x 0.5 x 1/0.38 m3/kg bw/day x (6.7 m3/10 m3) x 1.4
= 5.92 mg/m3
Step 3: Overall AF= 12.5
Dose response relationship AF: 1
The dose response relationship is considered unremarkable, therefore no additional factor is used.
Exposure duration AF: 1
No further extrapolation factor is needed since a chronic study was already used as starting point.
Allometric scaling AF: 1
No allometric scalling is applied for inhalation as the inhalative data is standardized with reference to the respiratory rates. Respiratory rates depend directly on caloric demand, therefore inhalative study results are already extrapolated to humans on the basis of metabolic rate scaling (=allometric scaling).
Interspecies AF, other differences: 2.5
The recommended AF for other interspecies differences is applied.
Intraspecies AF (worker): 5
The default value for the relatively homogenous group "worker" is used.
Whole database AF: 1
The quality of the whole data base is considered to be sufficient and uncritical.
AF for remaining uncertainties: 1
DNEL Derivation is considered conservative, reflecting reasonable worst
case assumptions. Therefore, no further AF for remaining uncertainties
is applied.
In conclusion,long term systemic inhalation DNEL, workers = 0.474 mg/m3
Acute, systemic DNEL- exposure via inhalation (workers)
The test item is not considered to become available as vapour due to its very low vapour pressure (< 1 Pa).
In a study conducted according to OECD Guideline 403 with Wistar rats, the effects of the test item exposed as aerosol were investigated. The maximum achievable aerosol concentration of the test item was administered for 4 hours (head exposure only). The test substance aerosol was directed into the animals’ noses. As no mortality occurred, the LC50 value was determined to be greater than the maximum achievable aerosol concentration.
Thus, the acute inhalation DNEL was not derived. Furthermore, long-term DNELs are considered sufficient to ensure that acute effects do not occur. In addition, the test item is not classified as acutely toxic via the oral, dermal or inhalation route.
Long term & acute, local DNEL- exposure via inhalation (workers)
In the acute inhalation toxicity study according to OECD Guideline 403, signs of nasal irritation during the 4 hours exposure period were observed. However, slight signs of irritation in the nasal cavity are in general regarded as unspecific findings commonly observed with high aerosol concentrations. The slight to moderate treatment related vascular lesions in the lungs, liver and kidney observed in the treated animals are considered a systemic effect. Based on the absence of mortality during the study, the test substance is not classified for acute systemic toxicity. It is also not classified for skin and eye irritation according to Regulation (EC) No 1272/2008, hence not indicating local mucosal membrane damage. Therefore, no DNEL is required.
Dermal
Long term, systemic DNEL- exposure via dermal route (workers)
There are no relevant experimental data on repeated dermal exposure. Therefore, long-term dermal DNEL was derived by route-to-route extrapolation.
The NOAEL of 4.8 mg/kg bw/day derived from an OECD TG 453 study performed with the test item was used as the Point of Departure.
Step 1: PoD: NOAEL = 4.8 mg/kg bw/day
Step 2: Modification into a correct starting point:
Correction for difference between human and experimental exposure conditions: 7 d rat/5 d worker.
Based on studies evaluating the absorption, a dermal absorption rate of 0.7 % and an oral absorption rate of 50 % have been identified. Therefore, the factor 50/0.7 has to be applied for modification into the correct starting point.
Dermal absorption 0.7 %, oral absorption 50 %
Corrected NOAEL (dermal) for workers:
= 4.8 mg/kg bw/day x 1.4 x 50/0.7
= 480 mg/kg bw/day
Step 3: Overall AF= 50
Dose response relationship AF: 1
The dose response relationship is considered unremarkable, therefore no additional factor is used.
Exposure duration AF: 1
No further extrapolation factor is needed since a chronic study was already used as starting point.
Allometric scaling AF: 4
The default allometric scaling factor for the differences between rats and humans is applied.
Interspecies AF, other differences: 2.5
The recommended AF for other interspecies differences is applied.
Intraspecies AF (worker): 5
The default value for the relatively homogenous group "worker" is used.
Whole database AF: 1
The quality of the whole data base is considered to be sufficient and uncritical.
AF for remaining uncertainties: 1
DNEL Derivation is considered conservative, reflecting reasonable worst
case assumptions. Therefore, no further AF for remaining uncertainties
is applied.
In conclusion, long term systemic dermal DNEL, workers = 9.6 mg/kg bw/day
Acute, systemic DNEL- dermal exposure (workers)
An acute dermal toxicity study is available for the test item. Based on the results the test item is not classified for acute dermal toxicity according to Regulation (EC) No 1272/2008 (CLP). Thus, the acute systemic dermal DNEL was not derived. Further, long-term DNELs are considered sufficient to ensure that acute effects do not occur.
Long term & acute, local DNEL- dermal exposure (workers)
The test substance is classified for skin sensitization, Cat 1. Therefore, appropriate qualitative risk managements measures should be implemented to avoid exposure. Thus, a qualitative risk assessment is applied and the substance is assigned to the high hazard band in accordance with ECHA Guidance on information requirements and chemical safety assessment Part E: Risk Characterisation (2016).
Hazard to the eye-local effects (worker)
The test item is not classified for eye irritation according to Regulation (EC) No 1272/2008 (CLP). Thus, no qualitative risk assessment is required.
References
ECHA (2012). Guidance on information requirements and chemical safety assessment. Chapter R.8: Characterisation of dose [concentration]-response for human health. Version 2.1, November 2012
ECHA (2016). Guidance on information requirements and chemical safety assessment. Part E: Risk Characterisation, Version 3.0, May 2016
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 83.5 µg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 25
- Dose descriptor starting point:
- NOAEL
- Value:
- 4.8 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 2.09 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Using a conservative approach, a general population DNEL (long-term inhalation exposure) is calculated. No repeated dose inhalation toxicity study with the test item is available. Therefore, the long-term inhalation DNEL was derived by route-to-route extrapolation from a chronic oral repeated dose toxicity study.
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable.
- AF for differences in duration of exposure:
- 1
- Justification:
- No further extrapolation factor is needed since a chronic study was already used as starting point.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No allometric scalling is applied for inhalation as the inhalative data is standardized with reference to the respiratory rates. Respiratory rates depend directly on caloric demand, therefore inhalative study results are already extrapolated to humans on the basis of metabolic rate scaling (=allometric scaling).
- AF for other interspecies differences:
- 2.5
- Justification:
- The recommended AF for interspecies differences is used.
- AF for intraspecies differences:
- 10
- Justification:
- The default value for the relatively homogenous group "general population" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- DNEL Derivation is considered conservative, reflecting reasonable worst case assumptions. Therefore, no further AF for remaining uncertainties is applied.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.43 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 100
- Dose descriptor starting point:
- NOAEL
- Value:
- 4.8 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 342.86 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
There are no relevant experimental data on repeated dermal exposure. Therefore, long-term dermal DNEL was derived by route-to-route extrapolation.
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable.
- AF for differences in duration of exposure:
- 1
- Justification:
- No further extrapolation factor is needed since a chronic study was already used as starting point.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- The default allometric scaling factor for the differences between rats and humans is applied.
- AF for other interspecies differences:
- 2.5
- Justification:
- The recommended AF for interspecies differences is used.
- AF for intraspecies differences:
- 10
- Justification:
- The default value for the relatively homogenous group "general population" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- DNEL Derivation is considered conservative, reflecting reasonable worst case assumptions. Therefore, no further AF for remaining uncertainties is applied.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Acute/short term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 48 µg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 100
- Dose descriptor starting point:
- NOAEL
- Value:
- 4.8 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 4.8 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
No route-to-route-extrapolation necessary.
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable.
- AF for differences in duration of exposure:
- 1
- Justification:
- No further extrapolation factor is needed since a chronic study was already used as starting point.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- The default allometric scaling factor for the differences between rats and humans is applied.
- AF for other interspecies differences:
- 2.5
- Justification:
- The recommended AF for interspecies differences is used.
- AF for intraspecies differences:
- 10
- Justification:
- The default value for the relatively homogenous group "general population" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- DNEL Derivation is considered conservative, reflecting reasonable worst case assumptions. Therefore, no further AF for remaining uncertainties is applied.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
General
DNEL derivation for the test item is performed under consideration of the recommendations of ECHA, Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose-response for human health (Version: 2.1, November 2012).
Inhalation
Long term, systemic DNEL – exposure via inhalation (general population)
Using a conservative approach, a general population DNEL (long-term inhalation exposure) is calculated. No repeated dose inhalation toxicity study with the test item is available. Therefore, the long-term inhalation DNEL was derived by route-to-route extrapolation from an oral repeated dose toxicity study:
Based on an OECD TG 453 study with daily dietary administration of the test item at concentration levels of 0, 20, 60, 125 or 750 ppm to Crl: CD BR rats for a period of 52 weeks, a NOAEL for systemic toxicity and carcinogenicity of 125 ppm (4.8 mg/kg bw/d in males and 6.7 mg/kg bw/d in females) was determined. Therefore, the NOAEL of 4.8 mg/kg bw/d is applied as Point of Departure for DNEL derivation.
Step 1: Point of Departure (PoD): NOAEL = 4.8 mg/kg bw/day
Step 2: Modification of PoD:
Standard respiratory volume of the rat (sRVrat) for 24 hours: 1.15 m3/kg bw
Oral absorption of the rat/ inhalation absorption of humans (ABS oral-rat / ABS inh-human): 1/2 (default)
Corrected NOAEC (inhalation) for general population:
= 4.8 mg/kg bw/day x 1/1.15 x 0.5 m3/kg bw/day
= 2.087 mg/m3
Step 3: Overall AF= 25
Dose response relationship AF: 1
The dose response relationship is considered unremarkable, therefore no additional factor is used.
Exposure duration AF: 1
No further extrapolation factor is needed since a chronic study was already used as starting point.
Allometric scaling AF: 1
No allometric scalling is applied for inhalation as the inhalative data is standardized with reference to the respiratory rates. Respiratory rates depend directly on caloric demand, therefore inhalative study results are already extrapolated to humans on the basis of metabolic rate scaling (=allometric scaling).
Interspecies AF, other differences: 2.5
The recommended AF for other interspecies differences is applied.
Intraspecies AF (general population): 10
The default value for the relatively homogenous group "general population" is used.
Whole database AF: 1
The quality of the whole data base is considered to be sufficient and uncritical.
AF for remaining uncertainties: 1
DNEL Derivation is considered conservative, reflecting reasonable worst case assumptions. Therefore, no further AF for remaining uncertainties is applied.
In conclusion,long term systemic inhalation DNEL, general populations = 0.0835 mg/m3
Acute, systemic DNEL- exposure via inhalation (general populations)
The test item is not considered to become available as vapour due to its very low vapour pressure (< 1 Pa).
In a study conducted according to OECD Guideline 403 with Wistar rats, the effects of the test item exposed as aerosol were investigated. The maximum achievable aerosol concentration of the test item was administered for 4 hours (head exposure only). The test substance aerosol was directed into the animals’ noses. As no mortality occurred, the LC50 value was determined to be greater than the maximum achievable aerosol concentration.
Thus, the acute inhalation DNEL was not derived. Furthermore, long-term DNELs are considered sufficient to ensure that acute effects do not occur. In addition, the test item is not classified as acutely toxic via the oral, dermal or inhalation route.
Long term & acute, local DNEL- exposure via inhalation (general populations)
In the acute inhalation toxicity study according to OECD Guideline 403, signs of nasal irritation during the 4 hours exposure period were observed. However, slight signs of irritation in the nasal cavity are in general regarded as unspecific findings commonly observed with high aerosol concentrations.The slight to moderate treatment related vascular lesions in the lungs, liver and kidney observed in the treated animals are considered a systemic effect. Based on the absence of mortality during the study, the test substance is not classified for acute systemic toxicity. It is also not classified for skin and eye irritation according to Regulation (EC) No 1272/2008, hence not indicating local mucosal membrane damage. Therefore, no DNEL is required.
Dermal
Long term, systemic DNEL- exposure via dermal route (general populations)
There are no relevant experimental data on repeated dermal exposure. Therefore, long-term dermal DNEL was derived by route-to-route extrapolation.
The NOAEL of 4.8 mg/kg bw/day derived from an OECD TG 453 study performed with the test item was used as the Point of Departure.
Step 1: PoD: NOAEL = 4.8 mg/kg bw/day
Step 2: Modification into a correct starting point:
Based on studies evaluating the absorption, a dermal absorption rate of 0.7 % and an oral absorption rate of 50 % have been identified. Therefore, the factor 50/0.7 has to be applied for modification into the correct starting point.
Corrected NOAEL (dermal) for general populations:
= 4.8 mg/kg bw/day x 50/0.7
= 342.86 mg/kg bw/day
Step 3: Overall AF= 100
Dose response relationship AF: 1
The dose response relationship is considered unremarkable, therefore no additional factor is used.
Exposure duration AF: 1
No further extrapolation factor is needed since a chronic study was already used as starting point.
Allometric scaling AF: 4
The default allometric scaling factor for the differences between rats and humans is applied.
Interspecies AF, other differences: 2.5
The recommended AF for other interspecies differences is applied.
Intraspecies AF (general population): 10
The default value for the relatively homogenous group "general population" is used.
Whole database AF: 1
The quality of the whole data base is considered to be sufficient and uncritical.
AF for remaining uncertainties: 1
DNEL Derivation is considered conservative, reflecting reasonable worst case assumptions. Therefore, no further AF for remaining uncertainties is applied.
In conclusion, long term systemic dermal DNEL, general populations = 3.43 mg/kg bw/day
Acute, systemic DNEL- dermal exposure (general populations)
An acute dermal toxicity study is available for the test item. Based on the results the test item is not classified for acute dermal toxicity according to Regulation (EC) No 1272/2008 (CLP). Thus, the acute systemic dermal DNEL was not derived. Furthermore, long-term DNELs are considered sufficient to ensure that acute effects do not occur.
Long term & acute, local DNEL- dermal exposure (general populations)
The test substance is classified for skin sensitization, Cat 1 according to Regulation (EC) No 1272/2008 (CLP). Therefore, appropriate qualitative risk managements measures should be implemented to avoid exposure. Thus, a qualitative risk assessment is applied and the substance is assigned to the high hazard band in accordance with ECHA Guidance on information requirements and chemical safety assessment Part E: Risk Characterisation (2016).
Oral route
Long term, systemic DNEL – exposure via oral route (general population)
Using a conservative approach, a general population DNEL (long-term inhalation exposure) is calculated. Based on an OECD TG 453 study with daily dietary administration of the test item at concentration levels of 0, 20, 60, 125 or 750 ppm to Crl: CD BR rats for a period of 52 weeks, a NOAEL for systemic toxicity and carcinogenicity of 125 ppm (4.8 mg/kg bw/d in males and 6.7 mg/kg bw/d in females) was determined. Therefore, the NOAEL of 4.8 mg/kg bw/d is applied as Point of Departure for DNEL derivation.
Step 1: Point of Departure (PoD): NOAEL = 4.8 mg/kg bw/day
Step 2:
Overall AF= 100
Dose response relationship AF: 1
The dose response relationship is considered unremarkable, therefore no additional factor is used.
Exposure duration AF: 1
No further extrapolation factor is needed since a chronic study was already used as starting point.
Allometric scaling AF: 4
The default allometric scaling factor for the differences between rats and humans is applied.
Interspecies AF, other differences: 2.5
The recommended AF for other interspecies differences is applied.
Intraspecies AF (general population): 10
The default value for the relatively homogenous group "general population" is used.
Whole database AF: 1
The quality of the whole data base is considered to be sufficient and uncritical.
AF for remaining uncertainties: 1
DNEL Derivation is considered conservative, reflecting reasonable worst case assumptions. Therefore, no further AF for remaining uncertainties is applied.
In conclusion, long term systemic inhalation DNEL, general populations = 0.0048 mg/m3
Acute, systemic DNEL- exposure via oral route (general populations)
The test item is not classified for acute oral toxicity according to Regulation (EC) No 1272/2008 (CLP). Thus, no DNEL is required. Furthermore, long-term DNELs are considered sufficient to ensure that acute effects do not occur.
Hazard to the eye-local effects (general population)
The test item is not classified for eye irritation according to Regulation (EC) No 1272/2008 (CLP). Thus, no qualitative risk assessment is required.
References
ECHA (2012). Guidance on information requirements and chemical safety assessment. Chapter R.8: Characterisation of dose [concentration]-response for human health. Version 2.1, November 2012
ECHA (2016). Guidance on information requirements and chemical safety assessment. Part E: Risk Characterisation, Version 3.0, May 2016.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.